Mark Lamotte - Publications, H-index & Citations

Mark Lamotte

th(is)modeling bv, asse, belgiumcorrespondencemark.lamotte@this2modeling.com

26H指数

344论文数

2.3K被引数

收录论文 91

发表时间

The cost-effectiveness of subcutaneous semaglutide 2.4 mg in the management of people living with obesity and prediabetes in England 英格兰地区肥胖和糖尿病前期患者管理中使用2.4 mg皮下注射司美格鲁肽的成本效益分析

Journal of Medical Economics

IF3

2025-10-28

OAAI

Mafalda Ramos; Sara Larsen; Francesco Fusco; Mark Lamotte; Matthew Capehorn

Development and validation of a chronic kidney disease progression model using patient-level simulations

RENAL FAILURE

IF3

2024-10-21

OAAI

Ramos, Mafalda; Gerlier, Laetitia; Uster, Anastasia; Muttram, Louise; Steubl, Dominik; Frankel, Andrew H.; Lamotte, Mark

Examining the Impact of Structural Uncertainty Across 10 Type 2 Diabetes Models: Results From the 2022 Mount Hood Challenge

VALUE IN HEALTH

IF6

2024-10-01

OAAI

Altunkaya, James; Li, Xinyu; Adler, Amanda; Feenstra, Talitha; Fridhammar, Adam; Keng, Mi Jun; Lamotte, Mark; McEwan, Phil; Nilsson, Andreas; Palmer, Andrew J.; Quan, Jianchao; Smolen, Harry; Tran-Duy, An; Valentine, William; Willis, Michael; Leal, Jose; Clarke, Philip

The Correlation Between Body Mass Index and Health-Related Quality of Life: Data from Two Weight Loss Intervention Studies

ADVANCES IN THERAPY

IF4

2024-09-24

OAAI

Kral, Pavol; Holst-Hansen, Thomas; Olivieri, Anamaria V.; Ivanescu, Cristina; Lamotte, Mark; Larsen, Sara

The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of Diabetes

APPLIED HEALTH ECONOMICS AND HEALTH POLICY

IF3.3

2024-09-16

OAAI

Zhao, Ting; Tew, Michelle; Feenstra, Talitha; van Baal, Pieter; Willis, Michael; Valentine, William J.; Clarke, Philip M.; Hunt, Barnaby; Altunkaya, James; Tran-Duy, An; Pollock, Richard F.; Malkin, Samuel J. P.; Nilsson, Andreas; McEwan, Phil; Foos, Volker; Leal, Jose; Huang, Elbert S.; Laiteerapong, Neda; Lamotte, Mark; Smolen, Harry; Quan, Jianchao; Martins, Luis; Ramos, Mafalda; Palmer, Andrew J.

Cost-effectiveness of semaglutide 2.4 mg in chronic weight management in Portugal

DIABETOLOGY & METABOLIC SYNDROME

IF3.9

2024-04-30

OAAI

Miguel, Luis Silva; Soares, Mariana; Olivieri, Anamaria; Sampaio, Filipa; Lamotte, Mark; Shukla, Suramya; Conde, Vasco; Freitas, Paula; Costa, Joao; Borges, Margarida

Burden of Illness of Type 2 Diabetes Mellitus in the Kingdom of Saudi Arabia: A Five-Year Longitudinal Study 沙特阿拉伯王国2型糖尿病的疾病负担: 一项为期五年的纵向研究

ADVANCES IN THERAPY

IF4

2024-01-19

OAAI

Alharbi, Mohammed; Othman, Abdullah; Nahari, Ahmed Ali; Al-Jedai, Ahmed Hamdan; Cuadras, Daniel; Almalky, Faisal; Alazmi, Fayez; Almudaiheem, Hajer Yousef; Alshubrumi, Hamad; Alswat, Hameed; Alsahafi, Homaid; Sindi, Kamelia; Basaikh, Khadija; Alqahtani, Majed; Lamotte, Mark; Yahia, Moataz; Hassan, Mohamed El-Khedr; Almutlaq, Mohammed; Alroaly, Mohammed; Alzelaye, Somaya; Alghamdi, Zein

Treatment patterns and unmet needs in adults with classic congenital adrenal hyperplasia: A modified Delphi consensus study

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2022-11-18

OAAI

Auchus, Richard J.; Courtillot, Carine; Dobs, Adrian; El-Maouche, Diala; Falhammar, Henrik; Lacroix, Andre; Farrar, Mallory; O'Donoghue, Conor; Anatchkova, Milena; Cutts, Katelyn; Taylor, Natalie; Yonan, Chuck; Lamotte, Mark; Touraine, Philippe

Exploring different ways to predict mortality in a cost-effectiveness model for obesity

DIABETES RESEARCH AND CLINICAL PRACTICE

IF7.4

2022-04-01

OAAI

Lopes, S.; Grand, T.; Johansen, P.; Lamotte, M.; Olivieri, A. V.

Cost Effectiveness of the FreeStyle Libre System vs. Self-Monitoring of Blood Glucose in People with Type 2 Diabetes on Insulin Treatment Not Reaching Glycemic Goals in Sweden

DIABETES

IF7.5

2021-06-01

PREAI

Jendle, Johan H.; Eeg-Olofsson, Katarina; Svensson, Ann-Marie; Franzen, Stefan; Lamotte, Mark; Levrat-Guillen, Fleur

Evaluating the Ability of Economic Models of Diabetes to Simulate New Cardiovascular Outcomes Trials: A Report on the Ninth Mount Hood Diabetes Challenge

VALUE IN HEALTH

IF6

2020-09-01

OAAI

Si, Lei; Willis, Michael S.; Asseburg, Christian; Nilsson, Andreas; Tew, Michelle; Clarke, Philip M.; Lamotte, Mark; Ramos, Mafalda; Shao, Hui; Shi, Lizheng; Zhang, Ping; McEwan, Phil; Ye, Wen; Herman, William H.; Kuo, Shihchen; Isaman, Deanna J.; Schramm, Wendelin; Sailer, Fabian; Brennan, Alan; Pollard, Daniel; Smolen, Harry J.; Leal, Jose; Gray, Alastair; Patel, Rishi; Feenstra, Talitha; Palmer, Andrew J.

Projected Long-Term Clinical Benefit and Cost-Effectiveness of Empagliflozin Compared with Glimepiride in Patients with Type 2 Diabetes in China

DIABETES

IF7.5

2019-06-01

PREAI

Lamotte, Mark; Salem, Ahmed; Mettam, Sam R.; Ustyugova, Anastasia V.; Zhang, Edmund; Ramos, Mafalda

ASSOCIATION BETWEEN CARDIOVASCULAR DISEASE RISK FACTORS AND HYPOGLYCAEMIC EVENTS IN TYPE 2 DIABETES USING THE IQVIA CORE DIABETES MODEL

VALUE IN HEALTH

IF6

2019-05-01

OAAI

Altrabsheh, E.; Monteiro, S.; Ramos, M.; Gurjar, K.; Olivieri, A., V; Lamotte, M.